title: Is fulvestrant ("Faslodex") just another selective estrogen receptor modulator?
authors.affiliation: Cancer Research UK, Department of Medical Oncology, University of Manchester, Christie Hospital NHS Trust, Manchester, United Kingdom.
authors.forename: A
authors.initials: A
authors.lastname: Howell
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D000077267:Fulvestrant; D006801:Humans; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors* / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*
chemical_list: D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D000077267:Fulvestrant; D004958:Estradiol